Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 4
Submit an article Journal homepage
268
Views
4
CrossRef citations to date
0
Altmetric
Articles

The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry

Mónica Munera-Camposa Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2227-2993View further author information
ORCID Icon,
Jaime Vilar-Alejob Department of Dermatology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, SpainView further author information
,
Raquel Riverac Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, SpainView further author information
,
Jose-Manuel Carrascosaa Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0003-4266-0771View further author information
ORCID Icon,
Esteban Daudénd Department of Dermatology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP). Madrid, SpainView further author information
,
Enrique Herrera-Acostae Department of Dermatology, Hospital Universitario Virgen de la Victoria, Málaga, SpainView further author information
,
Antonio Sahuquillo-Torralbaf Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, SpainView further author information
,
Francisco J. Gómez-Garcíag Department of Dermatology, Hospital Universitario Reina Sofía, Cordoba, SpainView further author information
,
Ofelia Baniandrés-Rodríguezh Department of Dermatology, CEIMI Hospital General Universitario Gregorio Marañón, Madrid, SpainView further author information
,
Pablo de la Cuevai Department of Dermatology, Hospital Universitario Infanta Leonor, Madrid, SpainView further author information
,
Jose-Luis López-Estebaranzj Department of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, SpainView further author information
,
Isabel Belinchónk Department of Dermatology, Hospital General Universitario de Alicante-ISABIAL, Alicante, SpainView further author information
,
Marta Ferranl Department of Dermatology, Hospital del Mar, Parc de Salut Mar, Barcelona, SpainView further author information
,
Jose Riera-Monroigm Department of Dermatology, Hospital Clínic de Barcelona, UB, Barcelona, SpainView further author information
,
Lourdes Rodriguezn Department of Dermatology, Hospital Virgen del Rocío, Sevilla, SpainView further author information
,
Gregorio Carreterob Department of Dermatology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, SpainView further author information
,
Carmen García-Donosoc Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, SpainView further author information
,
Ferran Ballescáa Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, SpainView further author information
,
Mar Llamas-Velascod Department of Dermatology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP). Madrid, SpainView further author information
,
Enrique Herrera-Ceballose Department of Dermatology, Hospital Universitario Virgen de la Victoria, Málaga, SpainView further author information
,
Conrad Pujol-Marcof Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, SpainView further author information
,
Lula María Nieto-Benitoh Department of Dermatology, CEIMI Hospital General Universitario Gregorio Marañón, Madrid, SpainORCID Iconhttps://orcid.org/0000-0002-7609-2736View further author information
ORCID Icon,
Diana P. Ruiz-Genaoj Department of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, SpainView further author information
,
Mercè Alsinam Department of Dermatology, Hospital Clínic de Barcelona, UB, Barcelona, SpainView further author information
,
Miguel A. Descalzoo Research Unit. Fundación Piel Sana AEDV, Madrid, SpainView further author information
,
Ignacio García-Dovalo Research Unit. Fundación Piel Sana AEDV, Madrid, Spain;p Department of Dermatology, Complexo Hospitalario Universitario de Vigo, Vigo, SpainORCID Iconhttps://orcid.org/0000-0002-6881-5260View further author information
ORCID Icon & the BIOBADADERM Study Group show all
Pages 2110-2117 | Received 06 Apr 2021, Accepted 23 Apr 2021, Published online: 23 Mar 2022

  • Marques E, Paluch Z, Boháč P, et al. Epidemilogy of moderate-to-severe psoriasis: a comparison between psoriasis patients treated with biological agents, conventional systemic drugs and topical agents. J Dermatolog Treat. 2020;(10):1–14.
  • Langan SM, Seminara NM, Shin DB, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol. 2012;132:556–562.
  • Singh S, Young P, Armstrong AW. Relationship between psoriasis and metabolic syndrome: a systematic review. G Ital di Dermatologia e Venereol Organo Uff Soc Ital di Dermatologia e Sifilogr. 2016;151:663–677.
  • Asrih M, Jornayvaz FR. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? Mol Cell Endocrinol. 2015;418 Pt 1:55–65.
  • Masarone M, Federico A, Abenavoli L, et al. Non alcoholic fatty liver: epidemiology and natural history. Rev Recent Clin Trials. 2014;9:126–133.
  • De A, Duseja A. Natural History of Simple Steatosis or Nonalcoholic Fatty Liver. J Clin Exp Hepatol. 2020;10:255–262.
  • Abedini R, Salehi M, Lajevardi V, et al. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease. Clin Exp Dermatol. 2015;40(7):722–727. Oct
  • Gisondi P, Targher G, Zoppini G, et al. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009;51(4):758–764.
  • Gisondi P, Barba E, Girolomoni G. Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis. J Eur Acad Dermatol Venereol. 2016;30(2):282–287.
  • Madanagobalane S, Anandan S. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India. Australas J Dermatol. 2012;53:190–197.
  • Miele L, Vallone S, Cefalo C, et al. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009;51(4):778–786.
  • van der Voort EAM, Koehler EM, Dowlatshahi EA, et al. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study. J Am Acad Dermatol. 2014;70:517–524.
  • Yeung H, Takeshita J, Mehta NN, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 2013;149(10):1173–1179.
  • Maybury CM, Jabbar-Lopez ZK, Wong T, et al. Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies. Br J Dermatol. 2014;171:17–29.
  • Kalb RE, Strober B, Weinstein G, et al. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol. 2009;60:824–837.
  • Egeberg A, Gisondi P, Carrascosa JM, et al. The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis. J Eur Acad Dermatol Venereol. 2020;34:1695–1706.
  • Menter A, Gelfand JM, Connor C, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol. United States. 2020;82:1445–1486.
  • Dávila-Seijo P, Dauden E, Descalzo MA, et al. Infections in moderate to severe psoriasis patients treated with biological drugs compared to classic systemic drugs: findings from the BIOBADADERM Registry. J Invest Dermatol. 2017;137:313–321.
  • Sahuquillo-Torralba A, Carretero G, Rivera R, et al. The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm Registry: A prospective cohort study. J Am Acad Dermatol. United States. 2020;82:738–741.
  • Lopetuso LR, Mocci G, Marzo M, et al. Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver. Int J Mol Sci. 2018;19(8):2199.
  • Daudén E, Carretero G, Rivera R, et al. Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry. J Am Acad Dermatol. 2020;83(1):139–150. Jul
  • White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30:377–399. Feb
  • Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10:585–598. Apr
  • Ogdie A, Grewal SK, Noe MH, et al. Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study. J Invest Dermatol. 2018;138(4):760–767.
  • Ganzetti G, Campanati A, Offidani A. Non-alcoholic fatty liver disease and psoriasis: So far, so near. World J Hepatol. 2015;7:315–326.
  • Finet A, Viguier M, Chazouillères O, the Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie, et al. Liver test abnormalities in patients admitted for severe psoriasis: prevalence and associated risk factors. J Eur Acad Dermatol Venereol. 2016;30(10):1742–1748.
  • Conway R, Low C, Coughlan RJ, et al. Risk of liver injury among methotrexate users: A meta-analysis of randomised controlled trials. Semin Arthritis Rheum. 2015;45:156–162.
  • Kim BR, Yang S, Doh EJ, et al. Risk Factors Affecting Adverse Effects of Cyclosporine A in a Real-World Psoriasis Treatment. Ann Dermatol. 2018;30:143–149.
  • Gisondi P, Cazzaniga S, Chimenti S, et al. Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. J Eur Acad Dermatol Venereol. 2013;27:e30-41.
  • Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet. 2002;359(9317):1541–1549.
  • Llamas-Velasco M, Concha-Garzón MJ, García-Diez A, et al. Liver Injury in Psoriasis Patients Receiving Ustekinumab: A Retrospective Study of 44 Patients Treated in the Clinical Practice Setting. Actas Dermosifiliogr. 2015;106:470–476.
  • Allard J, Le Guillou D, Begriche K, et al. Drug-induced liver injury in obesity and nonalcoholic fatty liver disease. Adv Pharmacol. 2019;85:75–107.
  • Massart J, Begriche K, Moreau C, et al. Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. J Clin Transl Res. 2017;3:212–232.
  • Merlo G, Cozzani E, Burlando M, et al. Effects of TNFα inhibitors in patients with psoriasis and metabolic syndrome: a preliminary study. G Ital di Dermatologia e Venereol Organo Uff Soc Ital di Dermatologia e Sifilogr. 2020;155:14–18.
  • Ruiz de Morales JMG, Puig L, Daudén E, et al. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. Autoimmun Rev. 2020;19:102429.
  • Paquissi FC. Immune imbalances in non-alcoholic fatty liver disease: from general biomarkers and neutrophils to interleukin-17 axis activation and new therapeutic targets. Front Immunol. 2016;7:490.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.